vimarsana.com

Latest Breaking News On - Sychedelic - Page 1 : vimarsana.com

BetterLife Announces Intent to Complete Private Placement

VANCOUVER, British Columbia, May 03, 2024 (GLOBE NEWSWIRE) BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:.

British columbiaUnited kingdomBetterlife pharmaDavid mellesBetterlife pharma incQlife pharmaNon brokered private placementPrivate placementInvestor relations managerCanadian stock exchange betr cnBetterlife pharma inc

Negev Capital celebrates psychedelic medicine milestones across globe

Venture Capital firm, Negev Capital, holds a portfolio of companies creating neuropsychiatric drugs based on psychedelic molecules.

Rob conleyBeckley psytechKen belotskyLife sciencesCanada filament healthFilament healthNegev capitalUnited kingdom based beckley psytechBio therapeuticsNegev labsMarkets amp regulationsPreclinical researchClinical developmentContract manufacturing amp logisticsMergers and acquisitionsAtient centricity

Honeysuckle Rose

I've been watching old movies and listening to even older songs lately — no surprise there —mostly dipping into the early British career of Alfred.

United statesUnited kingdomSan franciscoNew zealandFats wallerMike bynumEmily robbTia carrereCollin yeoLance gordonMichael walkerJay vanceWayne campbellFulkerson hallGeorge kahumoku jrKahumoku jr

Clerkenwell Health s psychedelic drug trial seeks participants

Some forms of depression cannot be cured by current treatments including antidepressants or going to psychological counselling or psychotherapy.

United statesUnited kingdomCity ofHenry fisherBeckley psytechRob conleyNational library of medicineOffice of national statisticsClerkenwell healthTreatment resistant depressionHarley streetChief scientific officerTreatment resistantNational statisticsChief medicalScientific officer

Silo Pharma s ketamine implant for fibromyalgia shows promise

Silo Pharma’s dissolvable ketamine implant, initially targeting fibromyalgia and chronic pain, has seen success in early research.

Eric weisblumBio developmentsMarkets amp regulationsEmerging marketsChronic pain

vimarsana © 2020. All Rights Reserved.